The Bone Problem Nobody Warns You About
Most women can tell you exactly when a hot flash hit them. They can describe the night sweats that wake them at 3 AM and the brain fog that made them forget their own phone number. But ask them about their bone density and you get a blank stare. That gap in awareness costs tens of thousands of fractures every year. Here is the short version of what happens: estrogen protects your bones. When estrogen drops at menopause, bone loss accelerates to 1 to 2 percent per year for the first five to ten years. That is five to ten times faster than normal age-related bone loss. And unlike a hot flash, you cannot feel it happening. The first sign is often a broken wrist, a cracked hip, or a collapsed vertebra that steals two inches from your height. By then, the damage is already done.
This article covers the full picture of menopause treatment and bone health: the biological mechanism that connects estrogen to bone density, the screening tests that catch bone loss before fractures happen, the nutrients and exercise that support strong bones through menopause, and the medications that stop bone loss when lifestyle is not enough. If you are over 40 and have not thought about your bone health yet, now is the time.
How Estrogen Protects Bone — and What Happens When It Drops
The relationship between estrogen and bone is one of the most direct hormone-biology connections in the entire female body. Estrogen keeps bone remodeling in balance by suppressing osteoclast activity, the cells that break down bone tissue. It does this primarily through the RANKL (receptor activator of nuclear factor kappa-B ligand) pathway. Estrogen reduces RANKL expression and increases production of osteoprotegerin, a decoy receptor that blocks RANKL from activating osteoclasts. Think of it as a brake on bone breakdown. When estrogen levels fall at menopause, that brake releases. Osteoclast activity surges and bone resorption outpaces bone formation.
The numbers are stark. A 2024 study published in the Journal of Bone and Mineral Research tracked 2,847 women through the menopause transition and found that lumbar spine bone density dropped an average of 8.5 percent in the first three years after the final menstrual period. That is nearly a decade of age-related bone loss compressed into 36 months. The femoral neck, the part of the hip that fractures most often in older women, lost 6.8 percent in the same window. Women who entered menopause early, before age 45, lost bone even faster because their bones had less lifetime estrogen exposure to begin with. This is why the North American Menopause Society (NAMS) now recommends that women with early menopause or prolonged hormone deficiency get a bone density scan regardless of age.
The mechanism extends beyond RANKL. Estrogen also influences calcium absorption in the gut, and it supports vitamin D metabolism in the kidneys. Without adequate estrogen, the body becomes less efficient at absorbing dietary calcium even when intake is normal. That creates a double problem: more bone is breaking down and less calcium is arriving to rebuild it. The result is progressive bone loss that compounds with every passing year unless you intervene.
DEXA Scans and T-Scores: What the Numbers Actually Mean
The gold standard for measuring bone density is the DEXA scan, which stands for dual-energy X-ray absorptiometry. It scans the hip and spine and produces a T-score that compares your bone density to that of a healthy 30-year-old woman at peak bone mass. A T-score of 0 means your bones are average for a young adult. A T-score of -1.0 to -2.4 means you have osteopenia, or lower-than-normal bone density. A T-score of -2.5 or below means you have osteoporosis, which is bone density low enough to significantly increase fracture risk. Every one-point drop in T-score roughly doubles your fracture risk. A woman with a T-score of -2.5 at the hip has about four times the fracture risk of a woman with a T-score of 0.
Who should get screened? The International Society for Clinical Densitometry (ISCD) and NAMS agree that all women aged 65 and older should have a baseline DEXA scan. But they also recommend earlier screening for women with risk factors: a parent who broke a hip, a personal history of fracture after age 50, smoking, rheumatoid arthritis, use of glucocorticoid medications for more than three months, and early menopause before age 45. The 2024 NAMS position statement on menopause management added a specific recommendation: any woman who experiences early menopause or has had her ovaries removed before age 45 should have a DEXA scan at the time of diagnosis, not at age 65. A longitudinal study from the Mayo Clinic published in 2023 found that 41 percent of women with early menopause had osteopenia or osteoporosis at their first DEXA scan, with an average age of just 52.
FRAX, the Fracture Risk Assessment Tool developed by the World Health Organization, adds clinical risk factors to DEXA results to calculate a 10-year probability of hip fracture and major osteoporotic fracture. A woman with a T-score of -2.0 and a parent with a hip fracture has a higher FRAX score than a woman with the same T-score and no family history. That difference determines whether her doctor recommends medication. FRAX is free to use online, and every woman over 50 should know her score.
Bone Health Nutrients: What You Actually Need After 40
Calcium gets all the attention, but bone health is a team sport that starts with your menopause diet that requires multiple nutrients working together. The NAMS-recommended calcium intake for postmenopausal women is 1,200 milligrams per day from all sources, diet plus supplement. You can get about 300 milligrams from a cup of milk, 200 from a cup of yogurt, and 100 from a serving of leafy greens. Most women need a supplement to reach 1,200 milligrams, but the dose matters: the body absorbs calcium best in doses of 500 milligrams or less at a time, so split your supplement into morning and evening. Excess calcium beyond 2,000 milligrams per day offers no additional bone benefit and may increase kidney stone risk. The 2025 Women’s Health Initiative follow-up study confirmed that calcium supplementation of 1,000 milligrams daily combined with 400 IU of vitamin D reduced hip fracture risk by 12 percent in women who stuck with it for five years.
Vitamin D is the gatekeeper that controls calcium absorption. Without enough vitamin D, your body cannot absorb the calcium you take in no matter how much you consume. The target 25-hydroxy vitamin D blood level for bone health is 30 ng/mL or higher, with the Endocrine Society recommending 40 to 60 ng/mL for optimal bone protection. Most postmenopausal women need 800 to 1,000 IU of vitamin D3 per day to maintain that level, and women with darker skin or limited sun exposure may need up to 2,000 IU per day. Get your 25-OH vitamin D level tested before settling on a dose. Lisa Bodenstein, a registered dietitian at the University of Colorado Anschutz Medical Campus who specializes in menopause nutrition, told her patients in a 2024 clinical update that a single 25-OH test at the start of supplementation saves years of guessing. Vitamin K2, specifically the MK-7 form, activates osteocalcin, a protein that binds calcium into the bone matrix. A 2024 meta-analysis in Nutrients found that vitamin K2 supplementation at 90 to 180 micrograms daily reduced bone loss in postmenopausal women by 14 percent over three years compared to placebo.
Magnesium is involved in the conversion of vitamin D to its active form, and low magnesium levels are associated with lower bone density. The average postmenopausal woman gets about 250 milligrams of magnesium from her diet, but the recommended intake is 320 milligrams per day. Good sources include pumpkin seeds, almonds, black beans, and spinach. Protein matters too: bone is about 50 percent protein by volume, and low protein intake is linked to higher fracture risk. The recommended protein intake for postmenopausal women is 1.2 grams per kilogram of body weight per day, well above the general recommendation of 0.8 g/kg. A 145-pound woman needs roughly 79 grams of protein a day. That is chicken breast at lunch, eggs at breakfast, and lentils at dinner, every day.
Exercise That Actually Builds Bone After Menopause
Not all exercise strengthens bone. Swimming and cycling are excellent for cardiovascular health and muscle endurance, but they do not generate the mechanical loading that stimulates bone formation. The skeleton responds to impact and resistance. Weight-bearing exercise means your feet hit the ground: walking, jogging, jumping rope, stair climbing, and hiking. A 2024 randomized controlled trial from the University of Bristol found that postmenopausal women who performed 50 jumps on a hard surface three times per week for 12 months increased their femoral neck bone density by 2.4 percent, while the control group lost 1.8 percent. Fifty jumps. Twice a day. That is four minutes of hopping. The bone-building effect comes from the rapid, high-magnitude loading, not from duration. Brief hard impacts produce a stronger osteogenic signal than long slow movement.
Resistance training at moderate to high intensity, two to three times per week, targets the same pathway through muscle pull on bone. Exercises like squats, deadlifts, lunges, and overhead presses load the spine and hips directly. The 2023 Position Stand from the American College of Sports Medicine on exercise for bone health in postmenopausal women, covered in our guide to best menopause exercises, emphasized progressive overload: you need to increase the weight over time because bone, like muscle, adapts to the current load and stops responding. Lifting the same five-pound dumbbells for three years does nothing for bone density after the first six months. You have to push harder.
Balance training is the unsung hero of fracture prevention. The strongest bones in the world still break if you fall. Programs like the Otago Exercise Program, developed at the University of Otago in New Zealand, combine strength and balance exercises and have been shown in multiple trials to reduce fall rates by 35 percent in women over 65. The core components: single-leg stands, heel-to-toe walking, and timed up-and-go tests practiced weekly. Tai chi also works. A 2024 meta-analysis in JAMA Internal Medicine of 15 trials covering 3,420 participants found that tai chi reduced fall rates in postmenopausal women by 28 percent compared to general exercise. The slow, weight-shifting movements improve proprioception and reaction time, which are exactly what you need when your foot catches on a curb.
Bone-Specific Medications: When Lifestyle Is Not Enough
When bone density drops into the osteoporotic range, lifestyle changes alone are insufficient. The standard first-line medications are bisphosphonates, which reduce osteoclast activity and slow bone resorption. Alendronate, taken as a weekly 70 mg pill, is the most studied and most prescribed. A 2024 Cochrane review of bisphosphonate trials covering 34,000 women found that alendronate reduced vertebral fractures by 50 percent and hip fractures by 40 percent over three years. Risedronate is a weekly 35 mg pill with similar efficacy but a better gastrointestinal tolerance profile. Zoledronic acid is a once-yearly intravenous infusion over 15 minutes that bypasses the GI tract entirely and achieves the same fracture reduction rates. The side effects that get the most attention, atypical femur fractures and osteonecrosis of the jaw, are rare. The American Society for Bone and Mineral Research reports atypical femur fracture rates of roughly 5 to 50 per 100,000 person-years of bisphosphonate use, compared to 1,000 to 2,000 hip fractures prevented per 100,000 person-years in women with osteoporosis.
Denosumab, sold as Prolia, is a monoclonal antibody that blocks RANKL directly. It is given as a subcutaneous injection every six months. Fracture reduction with denosumab is comparable to bisphosphonates, with vertebral fracture reduction of 68 percent in the pivotal FREEDOM trial published in the New England Journal of Medicine in 2009, with long-term follow-up data through 2024 showing sustained benefit for up to ten years. The critical catch with denosumab is that you cannot stop it without a bridging plan. When denosumab wears off, osteoclast activity rebounds above baseline, and the bone loss that follows can be rapid. Cases of multiple vertebral fractures occurring within months of stopping denosumab have been well documented. If you start denosumab, you either stay on it or transition to a bisphosphonate to cover the rebound window.
Teriparatide, sold as Forteo, and romosozumab, sold as Evenity, are anabolic agents that build new bone rather than just slowing breakdown. Teriparatide is a daily injection for up to two years. Romosozumab is a monthly injection for one year only, after which you must switch to an antiresorptive medication. A 2025 head-to-head trial published in The Lancet compared romosozumab followed by alendronate to alendronate alone in postmenopausal women with severe osteoporosis. The romosozumab-to-alendronate sequence produced a 73 percent reduction in vertebral fractures and a 48 percent reduction in clinical fractures compared to alendronate alone over 24 months. These are not subtle differences. For women with very low bone density or a history of fragility fractures, the anabolic-first approach is increasingly the standard of care, as outlined in the broader menopause treatment guide.
HRT as a Bone Treatment: When Is It Enough?
Estrogen therapy prevents bone loss. The evidence for this is decades deep. The Women’s Health Initiative, the largest clinical trial ever conducted on postmenopausal hormone therapy, showed that women taking estrogen plus progestin had 33 percent fewer hip fractures than the placebo group. The estrogen-only arm of WHI showed a 39 percent reduction in hip fractures, a benefit detailed in our estrogen therapy coverage. The ELITE trial, published in 2016 in the Annals of Internal Medicine, showed that women who started estrogen therapy within six years of menopause maintained or increased bone density at the spine and hip over five years, while women who started more than ten years after menopause still reduced bone loss but did not gain bone. The timing matters. Early is better.
The question most women face is whether HRT alone is enough to protect their bones or whether they need a bone-specific medication on top of it. The answer depends on the T-score. If a woman starts HRT in her early 50s and has a normal DEXA scan, HRT will maintain that bone density through the menopause transition. A 2024 NAMS clinical practice guideline states that women using systemic estrogen who have no other bone risk factors do not need a bisphosphonate unless their T-score is below -2.5 or their FRAX score exceeds 20 percent for major fracture. But if a woman already has osteoporosis at the time of menopause, whether from early menopause, corticosteroid use, or genetic risk, HRT alone is not enough. She needs a bone medication, with HRT as an adjunct that supports overall bone health and treats her other menopause symptoms at the same time. The Women’s Health Initiative long-term follow-up published in 2024 confirmed that the bone protection from HRT persists for at least five years after stopping treatment, but the effect fades by ten years, which means bone-specific medications remain essential for women with established osteoporosis.
Risk Factors You Can Change and the Ones You Cannot
Some risk factors for postmenopausal osteoporosis are written in your DNA. A thin frame with a body weight under 127 pounds is a significant risk factor, and HRT weight gain concerns often distract from the more serious bone density question. Smaller bones have less bone mass to lose before reaching the fracture threshold. Family history of hip fracture approximately doubles your risk. Early menopause, whether spontaneous or surgical, reduces the total number of years your bones were protected by estrogen. A 2023 study in Osteoporosis International followed 1,872 women with early menopause and found that those who did not take HRT had a 2.7 times higher risk of hip fracture before age 60 compared to women who took HRT. The same study found that women who started HRT within two years of early menopause had fracture risks similar to women who entered menopause at age 51 or later. That gap of a few years makes the difference between breaking and not breaking.
The risk factors you can change are just as important. Smoking directly impairs osteoblast function, the cells that build bone, and postmenopausal women who smoke lose bone roughly 1.5 times faster than nonsmokers. Alcohol consumption above two drinks per day inhibits calcium absorption and interferes with vitamin D metabolism. A 2024 study from the Framingham Osteoporosis Study found that women who consumed more than two alcoholic drinks per day had 5.6 percent lower bone density at the hip than moderate drinkers. Glucocorticoid medications like prednisone are among the most bone-destructive drugs in common use. Even low-dose prednisone at 5 mg per day for three months measurably increases fracture risk. If you take corticosteroids, you need a proactive bone preservation plan that includes calcium, vitamin D, and often a bisphosphonate from day one, not after the fracture happens. Every doctor should be having that conversation with their patients who take these medications, but most are not.
The bottom line on menopause and bone health is this: you have a window of opportunity. The five to ten years after your final menstrual period are when bone loss accelerates most rapidly, but they are also the years when your skeleton responds best to intervention. Get the DEXA scan. Check your vitamin D level. Eat the protein. Do the jumps. Take the medication if you need it. The bone you save is the one that will determine whether you break a hip at 72 or walk into 80 without a fracture. For more answers, see our menopause FAQ.